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Background: Pulmonary tularaemia is a very rare disease with only a small number of cases described in the literature.
So far, to our knowledge, there exists no case report of pulmonary tularaemia where PET-CT scans and follow up CT scans
are available.
Case presentation: We present four consecutive cases of pulmonary tularaemia. All patients suffered from non-specific
symptoms. All patients were referred to our institution with strong suspicions of malignancy, particularly lung cancer.
Diagnosis of tularaemia was made by typical findings in the aspirate of EBUS guided fine needle aspiration (necrosis,
epithelioid cell aggregation) and surgical biopsy respectively, and a positive serology. In three of the four cases, the
diagnosis was confirmed by positive PCR results of the tissue. PET-CT scans obtained in all four cases were
indistinguishable from lesions typically seen in patients suffering from lung cancer.
One of the four patients suffered from recurrence of the disease after antibiotic treatment; also this patient finally
recovered after initiation of a second antibiotic regimen. One case became asymptomatic spontaneously, but this
patient still received an antibiotic treatment.
In one case, a follow up CT scan was unchanged compared to the initial PET-CT scan; in all other cases, the lesions
disappeared almost completely.
Conclusions: Symptoms of patients suffering from pulmonary tularaemia are non-specific and can be of prolonged
character. PET-CT scans in these cases are indistinguishable from lung cancer. The diagnosis can be established when
typical findings in EBUS guided fine needle aspirates or surgical biopsies are found in combination with a positive
serology. In most cases the lesions disappear in follow up CT scans after clinically successful treatment.
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Due to their frequent occurrence, pulmonary malignan-
cies are sometimes considered spot diagnoses. This is
particularly true when modern techniques like positron
emission tomography CT fusion scans (FDG-PET-CT-
scans) are applied. Due to their high sensitivity and spe-
cificity, characteristic images and patterns can easily
mislead to premature diagnosis of malignancy.
Pulmonary tularaemia on the other hand is a very rare
disease with only a limited number of case reports and
case series existing in the literature. Tularaemia is a rare* Correspondence: siran@gmx.ch
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unless otherwise stated.zoonosis caused by Francisella tularensis. Different clin-
ical manifestations such as oropharyngeal type, ulcero-
glandular type, oculoglandular type or typhoidal type
have been reported. Pulmonary involvement occurs as a
distinct pattern or association with other forms of the
disease. In the literature, the frequency of pulmonary in-
volvement varies substantially. In a review of 22 cases
from Arkansas suffering from typhoidal tularaemia, 83%
showed pulmonary involvement [1]. In a large cohort re-
port of a tularaemia outbreak in Bulgaria, only nine
(3.4%) out of 262 affected patients clinically showed pul-
monary tularaemia [2]. Respiratory tularaemia may
manifest with dry cough, chest pain, fever and dyspnea.
The radiological presentation, in addition, varies mark-
edly in the different case series available. Whereas lobarral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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most frequently reported [1,3,4], pleural effusions [4]
and hilar adenopathy have also been observed [5]. To
our knowledge, cases where FDG-PET-CT scans are
available have not yet been described.
We present four consecutive cases with pulmonary tu-
laraemia which have been treated at our institution and
of which PET-CT scans and follow up CT scans are
presented.Case presentation
Patient No 1
A 62 year old otherwise healthy pastor was referred to
our institution due to dry cough, weight loss of 7 kilo-
grams (9% of body weight) and night sweats. He was a
lifelong non-smoker. The symptoms had lasted for about
eight weeks. The chest x-ray showed an enlarged left
hilus. Computed tomographic (CT) scan of the chest
showed a hilar mass of three centimeters with enlarged
hilar and mediastinal lymphnodes and a pulmonary nod-
ule of 7 millimeters in the lower left lobe. All of these le-
sions were highly avid for Fludeoxyglucose in the
consecutive positron emission tomography CT fusion
scan (FDG-PET-CT, Figure 1) and no other pathological
findings were seen. Bronchoscopy failed to reveal any
endobronchial abnormality. However, with the aid of
endobronchial ultrasonography (EBUS) we were able to
identify the hilar mass and to perform EBUS guided
transbronchial fine needle aspiration (TBNA) of this lesion.
The aspiration revealed normal lymphocytes, necrosis and
aggregations of epitheloid cells. No malignant cells were
seen. Due to high suspicion of malignancy, thoracoscopic
hilar lymphadenectomy was performed. Microscopic exam-
ination of the biopsy specimen showed necrotic granuloma
(Figure 2). Staining of the biopsy for mycobacteria was
negative. In a next step, serological testing for Bartonella
henselae, Brucella and Francisella tularensis revealed a titer
of 1:320 for Francisella tularensis, whereas the others were
negative. Nested PCR was performed on the biopsy
specimen for Francisella tularensis and this too was
positive. Although the patient was asymptomatic at this
time, we established an antibiotic treatment with doxy-
cyclin for the duration of three weeks. After this period,
the patient returned to our outpatient clinic with fever
and night sweats. This presentation was highly suggest-
ive of a recurrence of an infection with Francisella
tularensis. After an antibiotic therapy with garamycin
for one week and ciprofloxacin for additional two
weeks, the patient's condition improved rapidly. The
subsequent course of the patient was uneventful for a
follow up period of 27 months. A CT scan performed
after the second antibiotic treatment showed a smaller
residual lesion (Table 1).Patient No 2
A 49 year old forest official had been well until six weeks
before presentation, when fever, intermittent headache and
fatigue developed. A chest x-ray and subsequent CT scan
revealed multiple nodules in the lower right lobe and en-
larged hilar and mediastinal lymphnodes. The patient was
referred to our institution for further diagnostic work-up.
Bronchoscopy revealed distinct signs of acute bronchitis
and an EBUS guided TBNA of the enlarged subcarinal
lymph node was done. The aspirate showed necrosis and
epithelioid cell aggregations. Since the intrathoracic lesions
were highly suggestive of malignancy, a PET-CT scan was
performed. All visible pulmonary nodules - as well as the
hilar and subcarinal lymph nodes - were highly avid for
FDG. Since the aspirate of a repeated TBNA of the subcar-
inal lymphnode again revealed lymphocytes and epitheloid
cell aggregates, we decided to send the patient for diagnos-
tic mediastinoscopy. However, considering the previous ex-
perience with patient number one, we additionally sent the
patient's serum to be analyzed for Francisella agglutination
titer, which was highly elevated (Table 1). Subsequently, we
cancelled mediastinoscopy and sent aspirate from the
TBNA of the subcarinal lymphnode to perform nested
PCR for Franzisella tularensis. This proved to be positive.
Antibiotic therapy with ciprofloxacin was established for
three weeks and the patient recovered slowly over a time
period of about six weeks. A follow up CT scan of the
thorax two months after termination of the antibiotic treat-
ment, documented unremarkable findings, apart from a
small scar in the parenchyma of the lower right lobe
(Figure 1).
Patient No 3
A 52 year old businessman was referred by his general
practitioner due to weight loss of about 15% of body
weight, headache and fever. The patient had a 25 pack
year smoking history. The symptoms started three weeks
before referral. On examination, the temperature was
39.5°C and a pleural rub was heard over the left side of
the chest. A chest x-ray and a consecutive CT scan re-
vealed a left hilar mass with central necrosis and mul-
tiple enlarged hilar and mediastinal lymph nodes. A
bronchoscopy was performed. Apart from signs of an
acute bronchitis, the investigation was macroscopically
normal. EBUS guided TBNA of an enlarged left-sided
hilar lymph node was performed. The aspirate showed
lymphocytes and was negative for malignant cells and
for PCR for M. tuberculosis. Blood cultures and cultures
of bronchial aspiration fluid remained sterile. After
bronchoscopy, the general condition of the patient dete-
riorated further and empiric antibiotic treatment with
ceftriaxone was started. Due to a subsequent rash which
developed within two days of beginning the ceftriaxone,
the antibiotic treatment was changed empirically to
Figure 1 PET-CT and CT scans, respectively, of four patients suffering from pulmonary tularemia (initial presentation (a) and after
completed antibiotic treatment (b)).
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improved and the fever disappeared, the antibiotic ther-
apy was stopped after ten days. The patient returned
home and was advised to see his general practitioner for
follow-up consultations, particularly to perform an X-ray
of the chest after recovery.
After six weeks, the patient was reassigned due to recur-
rent fever, night sweats and fatigue. Due to suspicion of
lung cancer, a PET-CT scan was performed. The left hilar
mass had increased in size and the hilar and mediastinallymphadenopathies were unchanged when compared to
the former CT scan. The lesions were highly FDG avid
(Figure 1). We decided to repeat EBUS guided TBNA of
the left hilar lymph node and the aspirate showed necrosis
and epitheloid cell aggregations. Since PCR for M. tuber-
culosis and the culture results obtained from the former
aspirate were negative, tuberculosis was considered un-
likely. Serum of the patient was then sent to be analyzed
for Francisella agglutination titer, which was highly ele-
vated (Table 1). Antibiotic treatment with ciprofloxacin
Figure 2 Hilar lymph node from patient No 1 demonstrating necrotic granuloma (hematoxylin eosin 10× (a) and 20× (b)).
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slowly. A CT scan three months after stopping the anti-
biotic treatment was unchanged when compared to the
PET-CT scan. By that time, his neutrophil count had re-
covered and he was feeling well - as he was sixteen
months later.
Patient No 4
A 40 years old topographer had been suffering from
fever and a cough that had lasted for two weeks, when
he was treated with clarithromycin by his general practi-
tioner. Due to persistently elevated leucocytes, the anti-
biotic treatment then was changed to cefpodoxime.
Although his general condition improved and the ele-
vated leucocytes subsequently became normal, a chest x-
ray showed a right hilar mass. A CT scan revealed a 5cm
mass in the middle lobe and an enlarged subcarinal
lymph node. The patient was referred for further evalu-
ation of suspected lung cancer. EBUS guided TBNA ofthe enlarged subcarinal lymph node showed normal lym-
phocytes. A later PET-CT scan revealed a highly FDG
avid lesion of the middle lobe, as well as a highly positive
subcarinal lymph node (Figure 1). No other lesions were
detectable. We decided to repeat EBUS guided TBNA of
the subcarinal lymph node in addition to an EBUS
guided TBNA of the pulmonary mass. In both aspirates
normal lymphocytes were found. A thoracoscopic exci-
sion of an enlarged hilar lymph node revealed necrotiz-
ing granulomas. Polymerase chain reaction for M.
tuberculosis of the tissue was negative, but Francisella
agglutination titer in the serum of the patient was mark-
edly elevated. Later on the PCR of the lymph node for F.
tularensis was positive (Table 1). Though in the mean-
time the symptoms disappeared completely, we adminis-
tered an antibiotic treatment with ciprofloxacin for three
weeks. The CT scan of the chest that was performed
eight weeks later showed normal findings, except for a
small hilar scar (Figure 1).
Table 1 Findings, treatment and clinical course of four patients suffering from pulmonary tularemia
Patient No 1 No 2 No 3 No 4







Date of diagnosis Jan 12 Sep 12 Oct 2012 Oct 2012
Duration of symptoms before/after start
of therapy (weeks)
14/NA (spontanous recovery) 12/6 9/12 2/2
Agglutination titer for F. tularensis 1:320 1:5120 1:320 1:640
White-cell count (per mm3)/CRP (mg/liter)
at first presentation in our institution
4.2/6 11.4/87 5.1/83 6/<3
Nested PCR tissue for F. tularensis positive positive not done positive







Surgical biopsy yes not done not done yes
Probable vector rabbit feces tick unknown unknown
Treatment 1.doxycyclin ciprofloxacin ciprofloxacin ciprofloxacin
2.garamycin/cipro-floxacin
Course recurrence after doxycyclin remission remission remission
Length of follow up (months) 27 18 16 16






Mass in the middle,
enlarged lymph nodes
CT scan findings after completed
treatment
Residual lesion Small residual
parenchymal scar
unchanged Small residual hilar
scar
CRP: C-reactive protein, EBUS-TBNA: endobronchial ultrasound guided transbronchial needle aspiration, CT: computed tomography, PCR: polymerase chain reaction;
NA: not applicable.
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Francisella tularensis is a pathogenic species of Gram-
negative bacteria. It is a fastidious, facultative intracellular
bacterium that is spread by aerosol with high virulence. De-
pending on the side of infection, tularaemia may present
with several clinical manifestations, such as oropharyngeal,
ulceroglandular, occuloglandular or typhoidal type. Tular-
aemia is caused by contact with infected animals manly
such as rabbits and rodents. In this case series, the clinical
manifestations were nonspecific and, in contrast to the ma-
jority of the reported cases, they were remarkably long last-
ing, both before and after initiation of antibiotic therapy
(Table 1).
To the best of our knowledge, our four cases are the first
described in the literature where PET-CT-scans are avail-
able. Several findings we observed with this technique are
remarkable. Firstly, in all four cases we did not detect any
other manifestation in the body except the lesions in the
lung and the hilar and mediastinal lymph nodes, respect-
ively. In our opinion, this fact strongly argues for a pri-
mary affection of the lungs as a result of inhalation of the
bacteria. Therefore, in our cases, hematogeneic spread
causing secondary pulmonary involvement seems unlikely.
Secondly, in all cases, the result of the PET-CT scan -
much like the result of the CT scan - was indistinguishable
from malignancy, particularly lung cancer. The latter
phenomenon has already been published in an earlierstudy [6]. The impressive PET-CT findings of the current
cases underline the necessity of intransigent and rigorous
work up for cancer diagnosis and cancer staging even in
cases with supposed highly typical PET-CT findings.
Thirdly, in combination with EBUS guided TBNA, a PET-
CT scan performed before bronchoscopy might be helpful
in defining the most promising target lesion in order to
reach the highest possible diagnostic yield. We believe that
representative and typical findings in EBUS guided TBNA
aspirates - in combination with positive serologic testing -
are sufficient to establish the diagnosis of pulmonary tular-
aemia and to start antibiotic treatment. Nevertheless, in
our opinion, two to three months after finishing the anti-
biotic treatment, a follow up CT scan is mandatory in this
form of tularaemia in order not to miss malignancy. Con-
sidering the rarity of pulmonary tularaemia, the severity of
consequences and the paucity of scientific data, this costly
approach seems justifiable.
The follow up CT scans of the current cases were inter-
esting in several ways. In two of the four cases beside a
small scar all changes disappeared subsequently whereas in
two cases the findings disappeared only partially and
remained mainly unchanged, respectively. Interestingly, this
latter particular patient (No 3) suffered the longest from
persistent symptoms after initiation of antibiotic treatment.
Both observations might be the consequences of persistent
inflammatory reaction.
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four cases described here.
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